Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
RB

ROBERT BUTORA

WILLIAMS AND JENSEN, PLLC · Washington, DC
Registered · LDAActive

Background

Career
Washington, DC · current
Government experience
Health Policy Advisor
Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
21
past 12 months
Filings
22
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEWhite House OfficeExecutive Office of the President (EOP)Centers For Medicare and Medicaid Services (CMS)Health & Human Services, Dept of (HHS)Office of Management & Budget (OMB)Veterans Affairs, Dept of (VA)

Specific issues

Animal health, issues impacting medicines and vaccines for animals.
Health Issues · 2026 Q1
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues.
Health Issues · 2026 Q1
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs.
Health Issues · 2026 Q1
Support for obesity drug coverage and access.
Budget/Appropriations · 2026 Q1
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Medicare/Medicaid · 2026 Q1
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.
Health Issues · 2026 Q1

Clients

2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings14
2026 Q1
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.")
Q1lda.gov →
2026 Q1
PFIZER
Q1lda.gov →
2026 Q1
MERCK & CO INC
Q1lda.gov →
2026 Q1
ZOETIS
Q1lda.gov →
2026 Q1
BRISTOL-MYERS SQUIBB COMPANY
Q1lda.gov →
2026 Q1
ACCESS TO HEALTH FOUNDATION
Q1lda.gov →
2026 Q1
PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Q1lda.gov →
2026 Q1
ABBVIE, INC.
Q1lda.gov →
2026 Q1
NOVO NORDISK INC.
Q1lda.gov →
2026 Q1
NOVOCURE INC.
Q1lda.gov →
2026 Q1
ORGANON
Q1lda.gov →
2026 Q1
GRAIL, LLC
Q1lda.gov →
2026 Q1
ELI LILLY & COMPANY
Q1lda.gov →
2026 Q1
SANOFI, U.S.
Q1lda.gov →